Search

Search Constraints

You searched for: Author/Creator Galluzzo, Marco

Search Results

2. Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study. (1st February 2021)

3. Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study. (1st February 2021)

6. Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: A cross-sectional study. Issue 4 (January 2019)

7. Guselkumab for treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and drug-survival for up to 148 weeks. (3rd April 2023)

8. HLA-Cw6 and other HLA-C alleles, as well as MICB-DT, DDX58, and TYK2 genetic variants associate with optimal response to anti-IL-17A treatment in patients with psoriasis. (1st February 2021)

10. Impact of secukinumab on patient-reported outcomes in moderate to severe plaque psoriasis: a review of clinical studies. (1st February 2021)